Sermorelin
FDA ApprovedAlso known as: GRF 1-29, GHRH 1-29
Educational Content Only
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The FDA has not evaluated many of the peptides discussed here. Always consult a licensed healthcare provider before making any health decisions.
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous Growth Hormone-Releasing Hormone (GHRH). It was FDA-approved for the diagnosis of growth hormone deficiency in children and has been studied for its ability to stimulate pituitary release of growth hormone.
The following areas have been examined in research contexts. This does not constitute medical advice or imply proven efficacy in humans.
- Muscle Recovery & Repair
- Growth Hormone Regulation
- Sleep Optimization
- Fat Loss & Metabolism
- Anti-Aging & Longevity
Sermorelin binds to GHRH receptors in the anterior pituitary gland, stimulating the production and secretion of growth hormone. Unlike exogenous HGH, it works through the body's natural regulatory feedback mechanisms.
FDA-approved for pediatric growth hormone deficiency diagnosis. Prescription use in adults is off-label. Side effects may include injection site reactions, flushing, and headache.
Selected peer-reviewed papers from research literature. These are educational references only and do not imply proven efficacy or safety in humans.
- Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?
Walker RF. (2006). Clinical Interventions in Aging.DOI: 10.2147/ciia.2006.1.4.307
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
Prakash A, Goa KL. (1999). BioDrugs.DOI: 10.2165/00063030-199912020-00007
Want to learn more?
Ask Research Chat about SermorelinHalf-Life
~10-20 minutes
Administration
subcutaneous injection, intravenous
Legal Status (US)
FDA-approved (prescription only). Available through compounding pharmacies for off-label use.
27 indexed research passages
Related Peptides
P21 is a short synthetic peptide derived from humanin with modifications intended to enhance potency and stability. Research has examined its potential roles in neuroprotection, cognitive function, and cellular survival signaling, particularly in the context of Alzheimer's disease models and age-related cognitive decline.
GHRP-2 (pralmorelin) is a synthetic hexapeptide and potent growth hormone secretagogue studied for its ability to stimulate pulsatile GH release through the ghrelin receptor. It has been investigated in clinical studies and is sometimes used diagnostically for growth hormone deficiency assessment in some countries.
Hexarelin is a synthetic hexapeptide and potent growth hormone secretagogue studied for its ability to stimulate GH release and its potential cardioprotective effects in animal models and early human studies.
Lemairamin is a plant-derived alkaloid (isolated as WGX-50 from Evodia lepta) studied in the context of neuroprotection and neurological aging. Research in animal models has examined its potential to protect neurons from amyloid-beta toxicity and oxidative stress, with interest in Alzheimer's disease research.